Amy Huang

Amy Huang

Auto-generated profile, based on publicly available information

Amy Huang

Department of Orthopaedic Surgery, University of California, Irvine, Orange, California, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
Su-Jeong KimSu-Jeong Kim
Su-Jeong Kim
BMBrendan Miller
Brendan Miller
NHNicolas G. Hartel
Nicolas G. Hartel
RRRicardo Ramirez
Ricardo Ramirez
RBRegina Gonzalez Braniff
Regina Gonzalez Braniff
PCPinchas Cohen
Pinchas Cohen
Mitochondrial DNA single nucleotide polymorphisms (mtSNPs) have been associated with a reduced risk of developing Parkinson’s disease (PD), yet the underlying mechanisms remain elusive. In this study, we investigate the functional role of a PD-associated mtSNP that impacts the mitochondrial-derived peptide (MDP) Small Humanin-like Peptide 2 (SHLP2). We identify m.2158 T > C, a mtSNP associated with reduced PD risk, within the small open reading frame encoding SHLP2. This mtSNP results in an alternative form of SHLP2 (lysine 4 replaced with arginine; K4R). Using targeted mass spectrometry, we detect specific tryptic fragments of SHLP2 in neuronal cells and demonstrate its binding to mitochondrial complex 1. Notably, we observe that the K4R variant, associated with reduced PD risk, exhibits increased stability compared to WT SHLP2. Additionally, both WT and K4R SHLP2 show enhanced protection against mitochondrial dysfunction in in vitro experiments and confer protection against a PD-inducing toxin, a mitochondrial complex 1 inhibitor, in a mouse model. This study sheds light on the functional consequences of the m.2158 T > C mtSNP on SHLP2 and provides insights into the potential mechanisms by which this mtSNP may reduce the risk of PD.

12 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SYShahabeddin Yazdanpanah
Shahabeddin Yazdanpanah
HHHana-Joy E. Hanks
Hana-Joy E. Hanks
CGCarla Guedikian
Carla Guedikian
JDJade Dai
Jade Dai
RLRowen Lin
Rowen Lin
DPDon Young Park
Don Young Park
Background: Biportal endoscopic decompression for lumbar spinal stenosis (LSS) may facilitate rapid recovery, yet early minimal clinically important difference (MCID) achievement across pathology-relevant patient-reported outcome measures (PROMs) here remains insufficiently characterized. Accordingly, this study evaluates early (six-week) MCID achievement and associated factors following biportal endoscopic decompression for LSS to supplement surgeon comprehension and patient expectation-setting. Methods: A prospectively maintained, single-center/surgeon database was retrospectively queried (2021–2026) for adult patients undergoing biportal endoscopic decompression without fusion for LSS-only indications. Cases were excluded based on factors such as missing data, complicating etiologies/procedures, or insufficient follow-up. The primary outcome was literature-anchored MCID achievement, defined as an improvement of ≥2 points in the visual analog scale (VAS)-back and VAS-leg PROMs, and ≥14.9 points in the Oswestry Disability Index (ODI). Statistics included paired comparisons, exploratory multivariable logistic regressions with odds ratios (ORs), sensitivity analyses, and subgroup examinations. Results: Ninety-nine patients were included (mean age = 70.0 ± 10.0 years; body mass index [BMI] = 27.2 ± 5.1 kg/m2; follow-up = 6 ± 0 weeks; 53.5% male). VAS-back improved from 6.1 ± 2.8 to 2.0 ± 2.1, VAS-leg from 6.9 ± 2.4 to 1.4 ± 2.1, and ODI from 42.9 ± 18.6 to 21.5 ± 15.1 (all p < 0.001). Six-week MCID achievement rates were 78.8%, 88.9%, and 63.6%, respectively, with significant pairwise differences (all corrected p < 0.05). Best-case/worst-case exclusion sensitivity analyses yielded achievement ranges of 60.3–83.3% for VAS-back, 67.3–90.4% for VAS-leg, and 46.2–71.8% for ODI. Higher preoperative VAS-back (odds ratio [OR] = 1.810) and ODI (OR = 1.183) were associated with respective MCID achievement. Male sex increased (OR = 4.727) and higher BMI decreased (OR = 0.859) odds of ODI-MCID achievement (both corrected p < 0.05), though findings were statistically limited. In the subgroup with postoperative radiculitis (23.2%), which is known to affect recovery and its perception, lower six-week ODI-MCID achievement was observed (43.5% versus 69.7%, p = 0.022). Conclusions: Biportal endoscopic decompression for LSS was associated with substantial six-week MCID achievement rates, with the highest achievement rate observed for VAS-leg. While baseline symptom severity was associated with MCID achievement, these relationships warrant cautious interpretation given the use of absolute change thresholds. These findings may help to inform patient counseling and early postoperative expectation-setting.

4 May 2026 in World Neurosurgery
Verified
Journal Article
Open access
SYShahabeddin Yazdanpanah
Shahabeddin Yazdanpanah
AHAmy Huang
Amy Huang
AKAndrew Kim
Andrew Kim
ACAkhil Chandekar
Akhil Chandekar
HHHana-Joy E Hanks
Hana-Joy E Hanks
HWHao-Hua Wu
Hao-Hua Wu
Multi-level posterior segmental spinal instrumentation procedures have increased considerably in recent decades; however, short-term findings remain incompletely generalized. Therefore, this study investigates 30-day outcomes following these procedures to better highlight profiles and associations. The ACS-NSQIP database (2014-2023) was queried for patients undergoing multi-level posterior segmental instrumentation. Cases with missing variables or select complexity-increasing add-ons were excluded. A composite any adverse event (AAE) variable was examined, alongside various other complication subgroupings. Statistics included descriptive transformations, multivariable logistic regressions, and threshold analyses, where appropriate. A total of 1348 patients were included (mean age = 60 ± 14; body mass index = 31 ± 7 kg/m2; 49% male; 83% medium-length constructs [3-6 levels]; 14% long [7-12]; 3% very long [13+]). AAE occurred in 24%: major in 21%, minor in 5%, and infection-related in 5%. Age (odds ratio [OR] = 1.019), male sex (OR = 0.694), disseminated cancer (OR = 2.628), admission-to-operation interval (OR = 1.033), and operative time (OR = 1.005) were independently associated with AAE (all P < 0.05). Relative to medium constructs, long (OR = 2.081) and very long (OR = 6.981) fixations showed progressively greater AAE odds (all P < 0.05). Threshold analysis identified an admission-to-operation cutoff of 1 day (76th percentile), with AAE rate increasing from 20% below to 34% above (Benjamini-Hochberg corrected P < 0.001). Similarly, operative time greater than 286 minutes (73rd percentile) corresponded to increased AAE odds (corrected P < 0.001), rising from 16% below to 42% above. In this decade-spanning analysis, multi-level posterior segmental spinal instrumentations demonstrated meaningful short-term complication rates. Targeted preoperative counseling and facilitation of timely operative intervention may be warranted, and future studies should further evaluate these associations.